TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
$ANTHROPIC·$MA····$INTC····$BLUE-ORIGIN·$SPCX····$CRWV····$CRM····$MSFT····$NVDA····$ORCL····$CURSOR·$AAPL····$OPENAI·$AMZN····$UBER····$GOOGL····$META····$TSLA····$DATABRICKS·$PERPLEXITY·$LYFT····$NBIS····$TSM····$LITE····$ANDURIL·
$ANTHROPIC·$MA····$INTC····$BLUE-ORIGIN·$SPCX····$CRWV····$CRM····$MSFT····$NVDA····$ORCL····$CURSOR·$AAPL····$OPENAI·$AMZN····$UBER····$GOOGL····$META····$TSLA····$DATABRICKS·$PERPLEXITY·$LYFT····$NBIS····$TSM····$LITE····$ANDURIL·
←

christian angermayer

T2 · manager / operator

German serial entrepreneur and investor who co-founded Alnylam Pharmaceuticals at age 20, founded Atai Life Sciences to bring psychedelic medicines to psychiatry, co-founded Compass Pathways, and launched Enhanced Games as a performance-enhancing drug-permitted sports league. Runs family office Apeiron Investment Group.

5 calls·5 names·80% bull·last heard 5 months ago·Generating Alpha Podcast
track record

no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY

top calls

highest conviction · one per company
1sthigh conviction
$ENHEnhanced Gamesposition

Angermayer backs Enhanced Games: medical PEDs as recovery tools for athletes

FDA-approved performance-enhancing drugs under medical supervision help athletes recover from sport-induced bodily damage; Enhanced Games runs clinical trials to prove safety and efficacy, shifting the moral debate and potentially changing global sports policy within 3 years.

Generating Alpha Podcast2026-05episode →
2ndhigh conviction
$ATAIAtai Life Sciencesposition

Angermayer's main holding Atai brings psychedelic medicines to mainstream psychiatry

Psychedelic compounds have near-zero downside when used medically with clinicians and can cure mental health issues; Atai is building the full suite of psychedelic medicines with first approvals expected early next year.

Generating Alpha Podcast2026-05episode →
3rdhigh conviction
$CMPSCompass Pathwaysposition

Angermayer seeded Compass Pathways, invested $1.5B proving psilocybin efficacy

Psilocybin can treat mental health with low doses; Compass proved the 1960s science works in modern trials, de-risking the entire psychedelic medicine category.

Generating Alpha Podcast2026-05episode →

most discussed · click a bar to filter

  • $ENH
  • $ATAI
  • $CMPS
  • $ALNY
  • $APEIRON-INVESTMENT-GROUP

recurring themes

  • Life Sciences & Drug Development1
  • Human Performance Enhancement1
  • Longevity & Aging1
5 total
$ENH
···
Enhanced Games
HIGHchristian angermayer·Generating Alpha Podcast·5 months ago·Episode 53: Christian Angermayer - Founder of Apeiron Investment Group· position
Angermayer backs Enhanced Games: medical PEDs as recovery tools for athletes
FDA-approved performance-enhancing drugs under medical supervision help athletes recover from sport-induced bodily damage; Enhanced Games runs clinical trials to prove safety and efficacy, shifting the moral debate and potentially changing global sports policy within 3 years.
"Aaron sort of this idea of the enhanced games was so much grounded in science because like meaning it starts that the other what we probably the Olympics like is the most intransp…"
44:35
$ATAI
···
Atai Life Sciences
HIGHchristian angermayer·Generating Alpha Podcast·5 months ago·Episode 53: Christian Angermayer - Founder of Apeiron Investment Group· position
Angermayer's main holding Atai brings psychedelic medicines to mainstream psychiatry
Psychedelic compounds have near-zero downside when used medically with clinicians and can cure mental health issues; Atai is building the full suite of psychedelic medicines with first approvals expected early next year.
"my main holding is is atai stock market listed. What I What we're doing now is bringing back various psychedelic medicines into the medical world. So, I don't want people to try i…"
15:45
$CMPS
···
Compass Pathways
HIGHchristian angermayer·Generating Alpha Podcast·5 months ago·Episode 53: Christian Angermayer - Founder of Apeiron Investment Group· position
Angermayer seeded Compass Pathways, invested $1.5B proving psilocybin efficacy
Psilocybin can treat mental health with low doses; Compass proved the 1960s science works in modern trials, de-risking the entire psychedelic medicine category.
"we just invested 1 and 1/2 billion with a tiny compass and we've proven that psychedelics work with fairly low doses. And the same when I looked at at Aaron's idea of enhanced gam…"
45:53
$ALNY
···
Alnylam Pharmaceuticals
HIGHchristian angermayer·Generating Alpha Podcast·5 months ago·Episode 53: Christian Angermayer - Founder of Apeiron Investment Group· position
Angermayer co-founded Alnylam on RNAi thesis, took public via SPAC at 25
RNAi technology could switch off genetic disease expression at the root cause, addressing a multi-billion dollar market with no existing treatments for genetic diseases.
"Now, it's called RNAi. Um and they talked about it. And I also want to admit like I understood only vaguely where they want to go, but I had a good feeling for Oh, wow, I think I…"
6:12
$APEIRON-INVESTMENT-GROUP
Apeiron Investment Group
HIGHchristian angermayer·Generating Alpha Podcast·5 months ago·Episode 53: Christian Angermayer - Founder of Apeiron Investment Group· position
Angermayer's family office Apeiron invests across lifecycle, seeds funds, and builds companies
Apeiron manages Angermayer's capital plus outside money, doing direct investments from seed to public equities, investing in third-party funds for diversification, and incubating unique companies like Atai and Enhanced Games where the firm's network provides unfair advantage.
"Atai is my is is both. So, we we So, it's my family office. So, a big part of the capital we manage is my own capital, but we also sponsor funds which we then manage. So, we also…"
28:31
8
Life Sciences & Drug Developmenttailwind
Psychedelic medicines near approval, will transform mental health treatment
Psilocybin and other psychedelics have near-zero downside when used medically with clinicians; first approvals expected early next year via presidential order, proving 1960s science works in modern trials and opening a new therapeutic category for mental health.
7
Human Performance Enhancementtailwind
Enhanced Games proves medical PEDs aid athlete recovery, shifting moral debate
FDA-approved performance-enhancing drugs under medical supervision help athletes recover from sport-induced bodily damage; Enhanced Games' clinical trial dataset will prove safety and efficacy, potentially changing global sports policy within 3 years and creating a new category of performance medicine.
7
Longevity & Agingtailwind
Hormone replacement therapy from 30s onward is key longevity intervention
Declining testosterone and estrogen drive aging symptoms; TRT and HRT starting in 30s/40s maintain youthful hormone levels, improving energy, cognition, and physical capacity. Angermayer personally uses TRT since age 30 as a foundational longevity practice.